• 제목/요약/키워드: Primary melanoma

검색결과 93건 처리시간 0.022초

기관지 및 늑골에 전이된 맥락막 흑색종의 수술적 치료 - 1예 보고 - (Surgical Resection of Metastatic Choroidal Melanoma in the Rib and Bronchus - A case report -)

  • 박병준;최용수
    • Journal of Chest Surgery
    • /
    • 제43권1호
    • /
    • pp.117-119
    • /
    • 2010
  • 맥락막 흑색종은 성인에서 가장 빈번한 안구 내 종양이다. 간, 폐, 뼈로 전이를 잘하며 그 예후는 나쁜 것으로 알려져 있다. 본 논문에서 저자들은 늑골 및 기관지에 전이된 맥락막 흑색종에 대하여 수술적 절제를 하였으며 이를 보고하고자 한다.

구강내 발생한 악성 흑색종 (MALIGNANT MELANOMA OF THE ORAL CAVITY;REPORT OF TWO CASES)

  • 양동규;정인교;김종렬;최갑림;박상준;문원룡
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제12권1호
    • /
    • pp.135-141
    • /
    • 1990
  • 저자등은 구강내 흑색병소를 가진 2명의 환자를 이학적 검사, 임상검사, 방사선 검사, 조직검사를 하여 악성흑색종(증례 I : Level IV, Stage II A, 증례 II : Level V, Stage II B)으로 진단하고 증례 I은 경부곽청술을 시행하지 않고 외과적 절제술만 시행하였는바, 술후 약 6주후에 악하임파결절이 증대되어 조직검사를 시행한 결과 전이성 악성흑색종으로 나와 DTIC를 이용한 전신적인 화학요법을 5회 시행하였다. 술후 22개월동안 관찰한 결과 재발은 없었다. 증례 II는 병소의 크기가 작았기 때문에 경부곽청술은 시행하지 않고 외과적 절제술만을 시행하였다. 8개월 동안 관찰한 결과 재발이나 전이는 발생하지 않았다.

  • PDF

다발성 폐종괴 및 기관지 점막으로 전이한 원발불명의 악성 흑색종 1예 (A Case of Unknown Primary Malignant Melanoma with Pulmonary and Endobronchial Metastasis)

  • 민영훈;김성욱;진희종;이태유;송헌호;이근석;이정애;박영이;현인규
    • Tuberculosis and Respiratory Diseases
    • /
    • 제53권2호
    • /
    • pp.196-201
    • /
    • 2002
  • 악성 흑색종은 멜라닌세포에서 발생하는 종양으로 전체 악성 종양의 3%를 차지하고, 피부, 안구, 피부주위점막에서 호발한다. 이들은 주로 피부, 림프절, 폐, 간, 골 등으로 전이되고 폐의 전이는 약 5~15%에서 일어난다. 그러나 기관지 점막으로의 전이는 흔하지 않다. 특히 기관지 및 폐장으로 전이된 원발불명의 악성 흑색종은 아직 보고된 예가 없다. 이에 저자들은 기침과 검은색 객담을 주소로 내원하였던 34세 남자환자에서 굴곡성 기관지 내시경 및 조직검사를 시행하여 vimentin, S-100 protein, HMB-45 염색에 양성을 보이는 양측 폐장 및 기관지점막으로 전이된 악성 흑색종을 경험하였기에 문헌고찰과 함께 보고하는 바이다.

The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up

  • Portinari, Mattia;Baldini, Gabriele;Guidoboni, Massimo;Borghi, Alessandro;Panareo, Stefano;Bonazza, Simona;Dionigi, Gianlorenzo;Carcoforo, Paolo
    • Annals of Surgical Treatment and Research
    • /
    • 제95권5호
    • /
    • pp.286-296
    • /
    • 2018
  • Purpose: Sentinel lymph node (SLN) biopsy (SLNB) is widely accepted for staging of melanoma patients. It has been shown that clinico-pathological features such as Breslow thickness, ulceration, age, and sex are better predictors of relapse and survival than SLN status alone. The aims of this study were to evaluate the long-term (10-year) prognostic impact of SLNB and to determine predictive factors associated with SLN metastasis, relapse, and melanoma specific mortality (MSM). Methods: This was a prospective observational study on 289 consecutive patients with primary cutaneous melanoma who underwent SLNB from January 2000 to December 2007, and followed until January 2014, at an Italian academic hospital. Results: SLN was positive in 64 patients (22.1%). The median follow-up was 116 months (79-147 months). Tenyear disease-free survival and melanoma specific survival were poor in patients with positive SLN (58.7% and 66.4%, respectively). Only the increasing Breslow thickness resulted independently associated to an increased risk of SLN metastasis. Cox regression analysis showed that a Breslow thickness >2 mm was an independent predictor of relapse, and male sex and Breslow thickness >2 mm was a predictor of MSM. At 10 years, SLN metastasis was not significantly associated to either relapse or MSM. Conclusion: After the fifth year of follow-up, SLN metastasis is not an independent predictive factor of relapse or mortality which are mainly influenced by the characteristics of the primary tumor and of the patient. Patients with a Breslow thickness >2 mm regardless of the SLN status should be considered at high risk for 10-year relapse and mortality.

Induction of caspase-dependent apoptosis in melanoma cells by the synthetic compound (E)-1-(3,4-dihydroxyphenethyl)-3-styrylurea

  • Kim, Ji-Hae;Jang, Young-Oh;Kim, Beom-Tae;Hwang, Ki-Jun;Lee, Jeong-Chae
    • BMB Reports
    • /
    • 제42권12호
    • /
    • pp.806-811
    • /
    • 2009
  • Recently, various phenolic acid phenethyl ureas (PAPUs) have been synthesized from phenolic acids by Curtius rearrangement for the development of more effective anti-oxidants. In this study, we examined the anti-tumor activity and cellular mechanism of the synthetic compound (E)-1-(3,4-dihydroxyphenethyl)-3-styrylurea (PAPU1) using melanoma B16/F10 and M-3 cells. Results showed that PAPU1 inhibited the cell proliferation and viability, but did not induce cytotoxic effects on primary cultured fibroblasts. PAPU1 induced apoptotic cell death rather than necrosis in melanoma cells, a result clearly proven by the shift of cells into sub-$G_1$ phase of the cell cycle and by the substantial increase in cells positively stained with TUNEL or Annexin V. Collectively, this study revealed that PAPU1 induced apoptosis in a caspase-dependent manner, suggesting a potential role as a cancer chemopreventive agent for melanoma cells.

Treatment of Malignant Melanoma by Downregulation of XIAP and Overexpression of TRAIL with a Conditionally Replicating Oncolytic Adenovirus

  • Li, Xin-Qiu;Ke, Xian-Zhu;Wang, Yu-Ming
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권4호
    • /
    • pp.1471-1476
    • /
    • 2012
  • Background and Aim: Currently available systemic therapies for malignant melanoma produce low response rates in patients, and more effective treatment modalities are clearly needed. The tumor necrosis factor (TNF)-related apoptosis-inducing ligand has a significant impact on therapy for patients with X-linked inhibitor of apoptosis protein-downregulation malignant melanoma. The primary objective of this study was to assess its therapeutic potential. Materials and Methods: We employed a conditionally replicating oncolytic adenoviral vector, named CRAd5.TRAIL/siXIAP, with the characteristics of over-expression of the therapeutic gene TRAIL and downregulation of XIAP in one vector. B16F10-luc cells were employed to detect anti-tumor activity of CRAd5.TRAIL/siXIAP in vitro and in vivo. Results: CRAd5.TRAIL/siXIAP enhanced caspase-8 activation and caspase-3 maturation in B16F10 cells in vitro. Furthermore, it more effectively infected and killed melanoma cells in vitro and in vivo than other adenoviruses. Conclusion: Taken together, the combination of upregulation of TRAIL and downregulation of siXIAP with one oncolytic adenoviral vector holds promise for development of an effective therapy for melanomas and other common cancers.

구강내 악성흑색종에 대한 임상연구 (CLINICAL STUDY ON MALIGNANT MELANOMA IN ORAL CAVITY)

  • 김욱규;허진호;황대석;김용덕;신상훈;김종렬;정인교
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제34권6호
    • /
    • pp.611-615
    • /
    • 2008
  • The prognosis of oral malignant melanoma is poor compared with cutaneous melanoma. It may be related to the difficulty of wide enough resection, the early hematogenous matastases, higher stage at initial diagnosis, and tendency to growth vertically. In the view of histological differences between oral mucosa and skin, it is impossible use Clark's and Breslow's classifications for prognosis. The great problem is that there is still no consensus on the treatment due to rarity. Because data collection from case reports is considered to be the best source of information and should be pooled to analyze key determinants of outcome, We analysed 6 cases of primary malignant melanoma of the oral cavity which were diagnosed and treated in Pusan National University Hospital on recent 7 years and reviewed the literatures. Immunohistochemical study on S 100 Protein, GP 100 (HMB-45) with biopsy was usable to confirm the melanoma. Three patients who were treated by surgery, chemotherapy are alive, but a patients who couldn't received benefit care surgically due to poor condition was died of distant metastasis, and two patients who refused to surgery are still alive. Neck dissection including wide excision is recommended if lymph node involvement is suspected. Additionally, adjuvant chemotherapy could be considered as supporting therapy for malignant melanoma.

Primary sinonasal mucosal melanoma simulated as cystic lesions: a case report

  • Shin, Sung-Ho;Seok, Hyun;Kim, Seong-Gon;Hong, Seong-Doo
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제44권1호
    • /
    • pp.29-33
    • /
    • 2018
  • Sinonasal mucosal melanoma (SNMM) in the maxillary sinus is a rare disease condition. Compared to oral mucosal melanoma, SNMM has a bulky, exophytic, and polypoid appearance, is weakly pigmented, and associated with unspecific symptoms. Due to these features, SNMM in the maxillary sinus has been misdiagnosed as nasal polyps and chronic sinusitis. In this case report, we described SNMM occurring in the right maxillary sinus simulated as a cystic or benign lesion. Cortical bone thinning and expansion were observed around the mass. The excised soft mass was encapsulated and weakly pigmented. The mass was clearly excised and covered with a pedicled buccal fat pad graft. Diagnosis using immunohistochemistry with S-100 and homatropine methylbromide-45 (HMB-45) is critical for proper treatment.

Complete Resection of Pulmonary Metastatic Melanoma

  • Kim, Jae-Jun;Park, Jae-Kil;Wang, Young-Pil
    • Journal of Chest Surgery
    • /
    • 제44권2호
    • /
    • pp.165-168
    • /
    • 2011
  • Background: The prognosis of melanoma metastasized to other organs is very poor. There have been many studies on metastatic melanoma in Western society, but there have been few studies done in Korea because of the small number of cases. Materials and Methods: A retrospective review of 7 patients who underwent complete resection of pulmonary metastases from melanoma from January 2005 to December 2009 was performed. When the primary lesion was controlled or simultaneously controllable and no other metastatic lesion was found, pulmonary resections were performed. We analyzed the clinical prognoses after the initial melanoma diagnosis. Results: Of the seven patients, one was male and six were female. The mean age was 58.2 years (range 45~71). Six patients had a single pulmonary lesion and one patient had three lesions confined to the same lobe. The mean disease-free interval was 43.5 months (0~146 months). Before pulmonary resection, 4 patients had received systemic therapy. After pulmonary resection, 6 patients received systemic therapy. Complete resection was confirmed histologically. The metastasectomy was performed by wedge resection (6 patients) or lobectomy (1 patient). There were no mortalities or complications. After pulmonary resection, 1 patient had recurrent multiple lesions in the lung and 4 patients had metastases to other organs. The organs were the liver, brain, pleura, and lymph nodes. The mean observation time was 31.6 months and 3 patients died during observation. The mean survival was 27.7 months (14~60 months) and the 1-year and 3-year survival rates were 100% and 42%, respectively. Conclusion: When patients were selected carefully, the complete resection of pulmonary metastatic lesions was considered a major therapeutic tool.